Evidence map›Paper›PMID 38546656›Full record

ReviewJournal of cellular and molecular medicine2024

Research progress of the netrins and their receptors in cancer.

Xing Gao, Jiazhou Ye, Xi Huang, Shilin Huang, Wenfeng Luo, Dandan Zeng, Shizhou Li, Minchao Tang, Rongyun Mai, Yongqiang Li and 2 more

Open access · goldAbstract readReview
In one paragraph

Review in Journal of cellular and molecular medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Research progress of the netrins and their receptors in cancer.Journal of cellular and molecular medicine · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Xing GaoDepartment of Digestive Oncology, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.
Jiazhou YeDepartment of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.
Xi HuangDepartment of Digestive Oncology, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.
Shilin HuangDepartment of Digestive Oncology, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.
Wenfeng LuoDepartment of Digestive Oncology, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.
Dandan ZengDepartment of Digestive Oncology, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.
Shizhou LiDepartment of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.
Minchao TangDepartment of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.
Rongyun MaiDepartment of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.
Yongqiang LiDepartment of Digestive Oncology, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.
Yan LinDepartment of Digestive Oncology, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.
Rong LiangDepartment of Digestive Oncology, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.ORCID 0000-0003-0343-3277
Guangxi Medical University · CN

Funding

Advanced Innovation Teams and Xinghu Scholars Program of Guangxi Medical UniversityGuangxi Medical and health key discipline construction projectGuangxi Medical University Outstanding Young Talents Training ProgramGuangxi Scholarship Fund of Guangxi Education DepartmentNanning Qingxiu District Science and Technology Project 2021007Nanning Qingxiu District Science and Technology Project 2021010Nanning Qingxiu District Science and Technology Project 2021012National Natural Science Foundation of China 82060427National Natural Science Foundation of China 82103297Youth Program of Scientific Research Foundation of Guangxi Medical University Cancer Hospital 2023-7
6 · The paper itself

Abstract

Netrins, a family of secreted and membrane-associated proteins, can regulate axonal guidance, morphogenesis, angiogenesis, cell migration, cell survival, and tumorigenesis. Four secreted netrins (netrin 1, 3, 4 and 5) and two glycosylphosphatidylinositols-anchored membrane proteins, netrin-G1 and G2, have been identified in mammals. Netrins and their receptors can serve as a biomarker and molecular therapeutic target for pathological differentiation, diagnosis and prognosis of malignant cancers. We review here the potential roles of the netrins family and their receptors in cancer.

Indexed as

NeoplasmsAnimalsBiological TransportCarcinogenesisCell DifferentiationMammalsMembrane ProteinsNetrinsMembrane ProteinsNetrinscancermembranenetrinsreceptorsecreted

Identifiers

PMID38546656
PMCPMC10977403
OpenAlexW4393256348

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.